health
The Guardian view on cancer treatments: new hope for patients now and in the future
A drug for pancreatic cancer shows immense promise, but we shouldn’t forget research in the field is a story of small victories
TL;DR
- Cancer research is characterized by small victories and incremental progress, not definitive 'wars' or final cures.
- New treatments emerging from the American Society of Clinical Oncology meeting include a jab for head and neck cancers and an immunotherapy for bladder cancer.
- Daraxonrasib, a new drug, has doubled survival time for pancreatic cancer patients in a clinical trial.
- Daraxonrasib targets the Ras family of molecules, which are often mutated in cancer cells and were previously considered undruggable.
- Trials are underway to test daraxonrasib in other cancers where Ras mutations are common, such as colorectal and small-cell lung cancers.
- Routine genetic screening allows for the identification of patients who would benefit from specific treatments, expanding drug efficacy.
- Cancer survival rates have significantly improved over the decades, reflecting a 'golden age' for cancer research characterized by new detection methods, drugs, and treatments.